SIREN : 813216348
MOYBIO is a French company founded 10 years ago, specialized in the sector Activités des sociétés holding. Based in MARLY (59770), this company of category PME shows in 2024 a revenue of 6 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 753 € | 4 312 € | 4 793 € | 6 983 € | 4 374 € | 5 421 € | 5 447 € | 3 371 € | 3 207 € |
| Net income | 23 186 € | -6 405 € | 3 644 € | 20 277 € | -5 943 € | 4 529 € | 24 148 € | 8 846 € | 110 756 € |
| EBITDA | -971 € | -1 061 € | -1 582 € | -1 303 € | -3 102 € | -3 276 € | -4 303 € | -4 954 € | -16 968 € |
| Net margin | 403.0% | -148.5% | 76.0% | 290.4% | -135.9% | 83.5% | 443.3% | 262.4% | 3453.6% |
In 2024, MOYBIO achieves revenue of 6 k€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +7.6%. Vs 2023, growth of +33% (4 k€ -> 6 k€). After deducting consumption (5 k€), gross margin stands at 274 €, i.e. a rate of 5%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -971 €, representing -16.9% of revenue. Positive scissor effect: EBITDA margin improves by +7.7 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 23 k€, i.e. 403.0% of revenue. This profit can be retained or distributed to shareholders.
5 753 €
274 €
-971 €
-970 €
23 186 €
-16.9%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 0%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Cash flow represents 403.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.0%
0.0%
403.042%
0.0
In 2024, the debt ratio of MOYBIO (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of MOYBIO (0.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of MOYBIO (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 0.77. Alert: short-term debt exceeds current assets. Risk of payment difficulties without cash reinforcement.
0.767
-781.977
In 2024, the liquidity ratio of MOYBIO (0.77) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of MOYBIO (-782.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 34 days. Excellent situation: suppliers finance 34 days of the operating cycle (retail model). WCR is negative (-7838 days): operations structurally generate cash. Notable WCR improvement over the period (-21%), freeing up cash.
-125 252 €
0 j
34 j
0 j
-7838 j
Based on 54 transactions of similar company sales
in 2024,
the value of MOYBIO is estimated at
15 572 €
(range 9 900€ - 71 681€).
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MOYBIO with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of MOYBIO in 2024 is 6 k€.
Yes, MOYBIO generated a net profit of 23 k€ in 2024.
The headquarters of MOYBIO is located in MARLY (59770), in the department Nord.
The tax return of MOYBIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MOYBIO operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.